"Hepatitis C" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
Descriptor ID |
D006526
|
MeSH Number(s) |
C02.440.440 C02.782.350.350 C06.552.380.705.440
|
Concept/Terms |
Hepatitis C- Hepatitis C
- Parenterally-Transmitted Non-A, Non-B Hepatitis
- Parenterally Transmitted Non A, Non B Hepatitis
- PT-NANBH
- Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis C".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis C".
This graph shows the total number of publications written about "Hepatitis C" by people in this website by year, and whether "Hepatitis C" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 0 | 1 | 1 |
1997 | 1 | 0 | 1 |
2001 | 5 | 1 | 6 |
2002 | 4 | 0 | 4 |
2003 | 5 | 0 | 5 |
2004 | 3 | 2 | 5 |
2005 | 4 | 0 | 4 |
2006 | 2 | 0 | 2 |
2007 | 3 | 1 | 4 |
2008 | 1 | 1 | 2 |
2009 | 2 | 1 | 3 |
2010 | 2 | 0 | 2 |
2011 | 3 | 0 | 3 |
2012 | 3 | 0 | 3 |
2013 | 2 | 1 | 3 |
2014 | 2 | 0 | 2 |
2015 | 2 | 3 | 5 |
2016 | 6 | 0 | 6 |
2017 | 3 | 3 | 6 |
2018 | 2 | 1 | 3 |
2019 | 3 | 1 | 4 |
2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hepatitis C" by people in Profiles.
-
Schreiner AD, Rockey DC, Moran WP. The Cost of Hepatitis C Testing Strategies in Primary Care Patients with Abnormal Transaminases. J Gen Intern Med. 2020 04; 35(4):1340-1342.
-
Moon AM, Green PK, Rockey DC, Berry K, Ioannou GN. Hepatitis C eradication with direct-acting anti-virals reduces the risk of variceal bleeding. Aliment Pharmacol Ther. 2020 02; 51(3):364-373.
-
Chung JH, Hong SH, Seo N, Kim TS, An HJ, Lee P, Shin EC, Kim HM. Structure-based glycoengineering of interferon lambda 4 enhances its productivity and anti-viral potency. Cytokine. 2020 01; 125:154833.
-
Schreiner AD, Bian J, Zhang J, Haulsee ZM, Marsden J, Durkalski-Mauldin V, Mauldin PD, Moran WP, Rockey DC. The Association of Abnormal Liver Tests with Hepatitis C Testing in Primary Care. Am J Med. 2020 02; 133(2):214-221.e1.
-
Bian J, Schreiner AD. Population-based screening of hepatitis C virus in the United States. Curr Opin Gastroenterol. 2019 05; 35(3):177-182.
-
Privette AR, White B, Ferguson PL, Norcross ED, Richey LE. A different form of injury prevention: Successful screening and referral for human immunodeficiency virus and hepatitis C virus in a trauma population. J Trauma Acute Care Surg. 2018 11; 85(5):977-983.
-
Meissner EG. The Gut-Liver Axis in Hepatitis C Virus Infection: A Path Towards Altering the Natural History of Fibrosis Progression? Clin Infect Dis. 2018 08 31; 67(6):878-880.
-
Calderwood AH, Day LW, Muthusamy VR, Collins J, Hambrick RD, Brock AS, Guda NM, Buscaglia JM, Petersen BT, Buttar NS, Khanna LG, Kushnir VM, Repaka A, Villa NA, Eisen GM. ASGE guideline for infection control during GI endoscopy. Gastrointest Endosc. 2018 05; 87(5):1167-1179.
-
Obajemu AA, Rao N, Dilley KA, Vargas JM, Sheikh F, Donnelly RP, Shabman RS, Meissner EG, Prokunina-Olsson L, Onabajo OO. IFN-?4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling. J Immunol. 2017 12 01; 199(11):3808-3820.
-
Brewer JD, Elston DM, Vidimos AT, Rizza SA, Miller SJ. Managing sharps injuries and other occupational exposures to HIV, HBV, and HCV in the dermatology office. J Am Acad Dermatol. 2017 Nov; 77(5):946-951.e6.